Clobetasol for Oral Graft-Versus-Host Disease

NCT01557517 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Oral Chronic Graft vs Host Disease

Interventions

DRUG: Clobetasol Oral Rinse
DRUG: Placebo oral rinse

Sponsor

National Cancer Institute (NCI)